{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:01:45Z","timestamp":1784210505336,"version":"3.55.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Aim:<\/jats:title>\n            <jats:p>The aim was to investigate the use of comprehensive pretreatment staging with multiple diagnostic modalities, including functional imaging and minimally invasive surgical procedures, in locally advanced pancreatic cancer (LAPC) patients. The primary objective was to detect occult metastatic disease using staging laparoscopy and 18F-FDG-positron emission tomography (PET)\/computed tomography (CT) scan. The study also evaluated treatment efficacy and outcomes in LAPC patients treated with combined therapies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>This study was a secondary analysis of three prospective studies of chemoradiotherapy (CRT) with or without induction chemotherapy (IC). The inclusion period was from December 2009 until February 2023. An intensified pretreatment staging was conducted for all LAPC patients. Patients without distant disease at initial staging, with borderline resectable or unresectable LAPC, were enrolled in CRT combination protocols (CRT with or without IC). IC regimens included GemOx or FOLFIRINOX for four cycles, followed by concurrent CRT with gemcitabine. The primary endpoint was the detection of occult metastatic disease, and secondary objectives included resection rate, treatment toxicity, overall survival (OS), progression-free survival (PFS), local control, and metastasis-free survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Out of the 134 LAPC patients, 33.5% were identified with metastatic disease. Of these, 23.1% had a positive exploratory laparoscopy. Additionally, 13.4% were identified as having distant metastases by 18-FDG PET\/CT. The median PFS for all patients who completed CRT was 14.3 months, and the median OS was 17.2 months. Resected patients after the combined therapies demonstrated significantly improved outcomes compared tonon-resected patients (median PFS, 22.5 months vs. 9.5 months, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001; median OS, 38.2 months vs. 13 months, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). Moreover, patients treated with IC followed by CRT showed significantly better outcomes compared to the upfront CRT group (median PFS, 19 months vs. 9.9 months, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001; median OS, 19.3 months vs. 14.6 months, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). At univariate logistic regression analysis, the adding of IC was the only predictor for resection rate (95% CI: 0.12\u20131.02, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.05), and this data was confirmed at multivariate analysis (95% CI: 0.09\u20130.98, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.04). Hematological and gastrointestinal toxicities were observed during treatment, with manageable adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The use of comprehensive pretreatment staging, including laparoscopy and 18F-FDG-PET\/CT scan, is an effective approach in identifying occult metastatic disease in LAPC patients. Our findings offer valuable insights into accurate staging and treatment efficacy, providing evidence-based support for optimal management strategies in LAPC patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000000755","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T11:07:05Z","timestamp":1695380825000},"page":"6081-6091","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies"],"prefix":"10.1097","volume":"110","author":[{"given":"Michele","family":"Fiore","sequence":"first","affiliation":[{"name":"Department of Medicine and Surgery, Research Unit of Radiation Oncology"},{"name":"Operative Research Unit of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Petrianni","sequence":"additional","affiliation":[{"name":"Operative Research Unit of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Trecca","sequence":"additional","affiliation":[{"name":"Operative Research Unit of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"D\u2019Ercole","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Research Unit of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Coppola","sequence":"additional","affiliation":[{"name":"Dipartimento di Chirurgia, Sapienza Universit\u00e0 di Roma, Viale Regina Elena 326"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"La Vaccara","sequence":"additional","affiliation":[{"name":"Operative Research Unit of General Surgery Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Taralli","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Nuclear Medicine Unit, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cimini","sequence":"additional","affiliation":[{"name":"Operative Research Unit of Radiology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Roma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Greco","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Research Unit of Radiation Oncology"},{"name":"Operative Research Unit of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edy","family":"Ippolito","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Research Unit of Radiation Oncology"},{"name":"Operative Research Unit of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Calcagni","sequence":"additional","affiliation":[{"name":"Dipartimento Universitario di Scienze Radiologiche ed Ematologiche, Universit\u00e0 Cattolica del Sacro Cuore"},{"name":"Dipartimento di Diagnostica per Immagini, Nuclear Medicine Unit, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Beomonte Zobel","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Research Unit of Radiology"},{"name":"Operative Research Unit of Radiology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Roma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Caputo","sequence":"additional","affiliation":[{"name":"Department of Surgery and Research Unit of General Surgery, Universit\u00e0 Campus Bio-Medico di Roma"},{"name":"Operative Research Unit of General Surgery Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Coppola","sequence":"additional","affiliation":[{"name":"Department of Surgery and Research Unit of General Surgery, Universit\u00e0 Campus Bio-Medico di Roma"},{"name":"Operative Research Unit of General Surgery Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ramella","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Research Unit of Radiation Oncology"},{"name":"Operative Research Unit of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando Maria","family":"D\u2019Angelillo","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Department of Biomedicine and Prevention, University of Rome \u201cTor Vergata\u201d, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10]]},"reference":[{"key":"R1-20250824","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"1","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"45845","DOI":"10.1038\/srep45845","article-title":"Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer","volume":"7","author":"Fiore","year":"2017","journal-title":"Sci Rep"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/cancers12061681","article-title":"Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM)","volume":"12","author":"Silvestris","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.21037\/jgo-22-1034","article-title":"Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review","volume":"14","author":"Fiore","year":"2023","journal-title":"J Gastrointest Oncol"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13014-015-0564-8","article-title":"Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer","volume":"10","author":"Fiore","year":"2015","journal-title":"Radiat Oncol"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000488372","article-title":"The role of staging laparoscopy in resectable and borderline resectable pancreatic cancer: a systematic review and meta-analysis","volume":"36","author":"Ta","year":"2019","journal-title":"Dig Surg"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ejso.2022.12.011","article-title":"The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial","volume":"49","author":"van Dongen","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00464-004-8165-x","article-title":"Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by Computed Tomography","volume":"19","author":"Liu","year":"2005","journal-title":"Surg Endosc"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ejso.2009.01.013","article-title":"Staging for locally advanced pancreatic cancer","volume":"35","author":"Morak","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/jhbp.408","article-title":"Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma","volume":"23","author":"Karabicak","year":"2016","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.ejso.2019.06.004","article-title":"Yield of staging laparoscopy before treatment of locally advanced pancreatic cancer to detect occult metastases","volume":"45","author":"Suker","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/SLA.0b013e3181b2fafa","article-title":"A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer","volume":"250","author":"Kauhanen","year":"2009","journal-title":"Ann Surg"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.dld.2014.03.011","article-title":"The role of (18)fluoro-deoxyglucose positron emission tomography\/computed tomography in resectable pancreatic cancer","volume":"46","author":"Crippa","year":"2014","journal-title":"Dig Liver Dis"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.critrevonc.2019.03.008","article-title":"Positron emission tomography with computed tomography imaging (PET\/CT) for the radiotherapy planning definition of the biological target volume: PART 2","volume":"139","author":"Fiorentino","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"1758835920936093","DOI":"10.1177\/1758835920936093","article-title":"Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard","volume":"12","author":"Bouchart","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejca.2021.10.023","article-title":"Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials","volume":"160","author":"van Dam","year":"2022","journal-title":"Eur J Cancer"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"28","DOI":"10.14701\/ahbps.22-052","article-title":"Neoadjuvant chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: Meta-analysis and trial sequential analysis of randomized controlled trials","volume":"27","author":"Hajibandeh","year":"2023","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2407-12-199","article-title":"A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma","volume":"12","author":"Hosein","year":"2012","journal-title":"BMC Cancer"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1470-2045(16)00172-8","article-title":"FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis","volume":"17","author":"Suker","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:12:32Z","timestamp":1756062752000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000000755","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"2023-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}